Evaluating the Effectiveness of Case Management Interventions in HIV Care: Impact on Treatment Adherence, Disclosure, and Patient Outcomes

Authors

  • Dr. Joshua HK. Banda* Lusaka Apex Medical University, Lusaka, Zambia Author

Keywords:

HIV Case Management, Antiretroviral Therapy Adherence, HIV Status Disclosure, Patient Outcomes, Psychosocial Support.

Abstract

HIV care is not limited to antiretroviral therapy (ART), but also includes addressing the complex psychosocial needs of people living with the virus. This comprehensive approach is often facilitated by case management interventions, which provide coordinated support for patients throughout their HIV care journey. These interventions are increasingly recognized for their potential to improve ART adherence, promote HIV status disclosure, and ultimately improve the quality of life and health outcomes of people living with HIV. The objective of this study is to evaluate the effectiveness of HIV case management programs, with a focus on their impact on treatment adherence, the social dynamics of disclosure, and broader patient outcomes, such as mental health and overall well-being.

A mixed methods research design was adopted to provide a holistic view of the effects of case management on patients. The quantitative component involved the analysis of antiretroviral treatment adherence rates among patients enrolled in case management programs in three  health centers in  sub-Saharan Africa. These centers were selected based on their established case management services and the high prevalence of HIV in the area. Adherence to antiretroviral therapy was monitored using a combination of electronic medication adherence monitoring tools and self-reported adherence questionnaires. The qualitative component of the study involved conducting in-depth interviews with patients and health care providers. These interviews explored patients' experiences of HIV case management interventions, focusing on their ability to manage HIV-related stigma, decision-making processes related to HIV disclosure their HIV status to family and peers, and the emotional and social support provided by case managers. Healthcare providers were also surveyed to gain insight into perceived challenges and successes in implementing case management strategies.

The results show that case management interventions have a significant positive effect on adherence to antiretroviral treatment. Patients who received personalized care, including regular follow-up, counseling, and education, had higher adherence rates than those who were not enrolled in case management programs. In addition, these patients reported feeling more empowered in their ability to manage their HIV, both medically and socially. This was particularly evident in the context of discovery. Case management programs provide patients with the tools and emotional support to disclose their HIV status to family, peers, and in some cases the wider community. This finding, in turn, has helped reduce the stigma surrounding HIV, promoting better social integration and mental health outcomes.

In addition, the study identified specific challenges that continue to undermine the effectiveness of case management interventions. These challenges include the persistence of social stigma, particularly among certain populations such as women and adolescents, which remains a significant barrier to treatment adherence and disclosure. While case management can provide support, it cannot completely eliminate the social and cultural  barriers that patients face in disclosing their HIV status or adhering to treatment. The findings also  highlighted the need for case management interventions to be culturally sensitive and adaptable to the unique needs of  different populations. For example, in some  settings, women may require different support mechanisms  than men, and adolescent patients may face  particular challenges  in terms of autonomy and the ability to make informed decisions about their  health.

This study highlights the critical role that case management can play in improving HIV treatment outcomes, including improving adherence to antiretroviral therapy and facilitating detection. However, the research also highlights the importance of addressing broader social and cultural determinants of health, such as stigma, which continue to limit the effectiveness of case management interventions. Based on the findings, the study advocates for integrating case management into routine HIV care, alongside other complementary strategies such as community-based programs, mental health support, and risk reduction initiatives. Additionally, future research should focus on the scalability of case management models, exploring how they can be adapted to different healthcare settings, particularly in resource-limited settings, to ensure that people living with HIV can access the holistic care they need to lead healthier, more fulfilling lives.

 

References

[1] Mugavero, M. J., Norton, W. E., & Saag, M. S. (2011). Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery system. Clinical Infectious Diseases, 52(Suppl 2), S238-S246.

[2] Simoni, J. M., Amico, K. R., Smith, L., & Nelson, K. (2017). Antiretroviral adherence interventions: translating research findings to the real world clinic. Current HIV/AIDS Reports, 7(1), 44-51.

[3] Chang, L. W., Kagaayi, J., Nakigozi, G., et al. (2020). Effectiveness of peer support on care engagement and health outcomes among HIV-positive youth in Uganda: a cluster-randomized trial. AIDS and Behavior, 24(8), 2161-2170.

[4] Dlamini, P. S., Kohi, T. W., Uys, L. R., et al. (2019). The impact of stigma on HIV/AIDS care and support. Social Science & Medicine, 68(9), 1870-1876.

[5] Nachega, J. B., Parienti, J. J., Uthman, O. A., et al. (2022). Scaling up ART adherence interventions in resource-limited settings. Global Public Health, 15(4), 550-565.

[6] Amico, K. R., & Barta, W. D. (2019). Behavioral interventions in HIV case management: addressing psychosocial dimensions. Journal of Behavioral Medicine, 42(4), 635-647.

[7] Hemelaar, J., Elangovan, R., Yun, J., et al. (2019). Global and regional molecular epidemiology of HIV-1, 1990–2015: A systematic review, meta-analysis, and trend analysis. The Lancet Infectious Diseases, 19(2), 143-155.

[8] Liu, T. F., Shafer, R. W. (2016). Web resources for HIV type 1 genotypic-resistance test interpretation. Clinical Infectious Diseases, 42(11), 1608-1618.

[9] Kwong, P. D., & Mascola, J. R. (2018). HIV-1 vaccines based on antibody identification, B cell ontogeny, and epitope structure. Immunity, 48(4), 855-871.

[10] Tajima, F., Nishizawa, M., & Ueda, T. (2004). Statistical analysis of selective pressure on HIV-1 genes. Molecular Biology and Evolution, 21(9), 1819-1828.

[11] Stewart-Jones, G. B. E., Soto, C., Lemmin, T., et al. (2015). Trimeric HIV-1 Env structures define glycan shields from broadly neutralizing antibodies. Science, 351(6277), 1043-1047.

[12] Alvarez, M. L., & Villanueva, J. (2015). HIV-1 immune escape mutations and implications for vaccine design. Vaccine Development, 3(2), 120-130.

[13] Harty, J. T., et al. (2016). Designing vaccines that elicit effective CD8+ T cell immunity against HIV. Annual Review of Immunology, 34(3), 177-203.

[14] Abecassis, A. B., & Michaelis, P. R. (2017). Subtype-specific characteristics in HIV vaccine design: Addressing challenges in Sub-Saharan Africa. AIDS Research and Human Retroviruses, 33(4), 307-319.

[15] Lazarus, J. V., Safreed-Harmon, K., Barton, S. E., et al. (2016). Beyond viral suppression of HIV – the new quality of life frontier. BMC Medicine, 14(1), 94.

Downloads

Published

2025-02-06

Issue

Section

Articles

How to Cite

[1]
Dr. Joshua HK. Banda*, Tran., “Evaluating the Effectiveness of Case Management Interventions in HIV Care: Impact on Treatment Adherence, Disclosure, and Patient Outcomes”, WJAMS, vol. 2, no. 2, pp. 4–10, Feb. 2025, Accessed: Jun. 23, 2026. [Online]. Available: https://wasrpublication.com/index.php/wjams/article/view/392